Sign in

Private company

Amryt Pharma plc

Amryt Pharma plc is a British pharmaceutical preparations company based in London, active since 2019.2

Last updated Oct 21, 2026.

Overview

$222.5MRevenue, fiscal 20213
$1.0MNet income, fiscal 20213
  • IndustryPharmaceutical Preparations2
  • HeadquartersLondon, United Kingdom2
  • Incorporated inUnited Kingdom4
  • Business addressDept 920A, 196 High Road, Wood Green, London, X0 N22 8Hh4
  • Filer categoryAccelerated filer, Emerging growth company4
  • Legal formPublic Limited Company2
  • LEI213800YNUJEOJ84L4T952
  • StatusActive2
  • LEI statusLapsed (not renewed)2
  • Registered addressDEPT 920A 196 HIGH ROAD, N22 8HH London, United Kingdom2
  • Registered withCompanies House, 121078592

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2021

52.3%Gross margin3
-17.3%Operating margin3
0.4%Net margin3
21.9%Revenue growth, 20213
0.3%Return on equity3
0.26×Debt to equity3
$14.8MFree cash flow3

Where the money goes

Where each dollar of revenue went, fiscal 2021

  • Cost of revenue43¢$106.1M
  • Research and development15¢$37.7M
  • Selling, general and admin38¢$92.0M
  • Income tax3¢$7.6M
  • Profit0¢$1.0M

Out of $222.5M in revenue.3

Where each dollar of operating cash went, fiscal 2021

  • Capital spending5¢$729.0K
  • Kept or used elsewhere95¢$14.8M

Out of $15.5M of cash from operations.3

Financial statements

Revenue53$222.5M in 2021+1202% since 2018
0$100.0M$200.0M$300.0M2018: $17.1M$17.1M20182019: $58.1M$58.1M2019+240%2020: $182.6M$182.6M2020+214%2021: $222.5M$222.5M2021+22%
Gross profit53$116.4M in 2021+975% since 2018
0$50.0M$100.0M$150.0M2018: $10.8M$10.8M20182019: $19.4M$19.4M2019+79%2020: $63.6M$63.6M2020+228%2021: $116.4M$116.4M2021+83%
Operating income53-$38.6M in 2021+114% since 2018
-$60.0M-$40.0M-$20.0M02018: -$18.0M-$18.0M20182019: -$50.5M-$50.5M2019+180%2020: -$46.5M-$46.5M2020−8%2021: -$38.6M-$38.6M2021−17%
Net income53$1.0M in 2021
-$150.0M-$100.0M-$50.0M0$50.0M2018: -$30.5M-$30.5M20182019: -$63.0M-$63.0M2019+107%2020: -$104.5M-$104.5M2020+66%2021: $1.0M$1.0M2021
Fiscal year20172018201920202021
Revenue$17.1M5$58.1M3$182.6M3$222.5M3
Cost of revenue$106.1M3
Gross profit$10.8M5$19.4M3$63.6M3$116.4M3
Research and development$37.7M3
Selling, general and admin$92.0M3
Operating income-$18.0M5-$50.5M3-$46.5M3-$38.6M3
Income before tax-$6.6M3
Income tax-$7.6M3
Net income-$30.5M5-$63.0M3-$104.5M3$1.0M3
Earnings per share-$0.833-$0.663$0.003
Earnings per share (diluted)-$0.833-$0.663$0.003
Shares (weighted, basic)235.9M shares3
Shares (weighted, diluted)247.0M shares3

Compare Amryt Pharma plc with another company

Corporate structure

Amryt Pharma plc sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of Amryt Pharma plc

  • Amryt Pharma plc London, United Kingdom

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What Amryt Pharma plc reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, net$7.4M3 Dec 31, 2021$7.6M3 Dec 31, 2020−2.1%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$113.0M3 Dec 31, 2021$118.8M3 Dec 31, 2020−4.9%

Intangibles and goodwill

ItemLatestA year beforeChange
Goodwill$56.7M3 Dec 31, 2021$19.1M3 Dec 31, 2020+196.3%
Intangible assets, net (excluding goodwill)$467.4M3 Dec 31, 2021$305.4M3 Dec 31, 2020+53.0%

Inventory

ItemLatestA year beforeChange
Inventory, total$115.8M3 Dec 31, 2021$41.0M3 Dec 31, 2020+182.4%

Former names

  • Amryt Pharma Holdings LtdAug 8, 2019 to Aug 8, 20194

Timeline

  1. Jul 17, 2019Founded Amryt Pharma plc is founded2

Filings

69 filings to the SEC since October 2021: 1 annual reports, 9 large holders, 59 other. The latest 20:

  1. Apr 24, 202315F-12B EDGAR
  2. Apr 21, 2023EFFECT EDGAR
  3. Apr 21, 2023EFFECT EDGAR
  4. Apr 21, 2023EFFECT EDGAR
  5. Apr 18, 2023SC 13G/A EDGAR
  6. Apr 18, 2023POS AM EDGAR
  7. Apr 18, 2023POS AM EDGAR
  8. Apr 18, 2023POS AM EDGAR
  9. Apr 12, 20236-K EDGAR
  10. Apr 3, 20236-K EDGAR
  11. Mar 23, 20236-K EDGAR
  12. Feb 16, 20236-K EDGAR
  13. Feb 13, 2023SC 13G/A EDGAR
  14. Feb 10, 2023SC 13G/A EDGAR
  15. Feb 10, 2023SC 13G/A AMRYT PHARMA PLC EDGAR
  16. Jan 9, 20236-K EDGAR
  17. Jan 3, 20236-K EDGAR
  18. Nov 3, 20226-K EDGAR
  19. Aug 4, 20226-K EDGAR
  20. Jul 1, 20226-K EDGAR

The 69 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

SEC filer profile

How Amryt Pharma plc is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARAmryt Pharma plc1
  • CIK0001783010
  • Filer statusAccelerated filer<br>emerging growth company1
  • Incorporated inUnited Kingdom1
  • Fiscal year endsDecember 311
  • Industry code (SIC)2834 Pharmaceutical Preparations1
  • Business addressDept 920A, 196 High Road, Wood Green, London, X0 N22 8HH1
  • Mailing address45 Mespil Road, Dublin 4, L2 D04 W2F11
  • Phone353-1-518-02001
  • Shares outstanding319,814,747 as of Dec 31, 20213
  • On EDGAR sinceAug 8, 20191
  • Filings164 in all: 6-K (53), 424B3 (35), EFFECT (9), SC 13G/A (9), 425 (6), CORRESP (6), SC 13G (6), UPLOAD (6)1
    All 25 form types

    424B4 (5), POS AM (5), DRS/A (3), F-1/A (3), 20-F (2), DRS (2), DRSLTR (2), F-1 (2), S-8 (2), 15F-12B (1), 25-NSE (1), 8-A12B (1), CERT (1), F-3 (1), F-4 (1), F-4/A (1), T-3/A (1)

  • Latest filingsAnnual report (20-F) Apr 29, 2022

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11